Home > Insider Trading > Filing (0000059478-24-000139)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
59478	Eli Lilly & Co	LLY	Pharmaceutical Preparations (2834)	350470950

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1702471	Johna Norton	Lilly Corporate Center Indianapolis IN 46285	Evp, Global Quality	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-06-03	7,056	$819.38	25,428	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	402	Indirect	401(k)
Common Stock	1,770	Indirect	401(k) - by partner
Common Stock	128	Indirect	by partner

Footnotes

The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2024.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $818.80 to $819.59, inclusive. The reporting person undertakes to provide to Eli Lilly and Company, any security holder of Eli Lilly and Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reporting person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.